es reicht aus, wenn du joelu sagst... o. T.  

ja stimmt, ifex läuft ja auch sensationell gut seit deinen Empfehlung­en vor weit über nem Jahr ...

Muahahahah­

Ähnlich wie Netlife, ähhh Augrid ähhh ... ach ja, du hast ja zum Glück immer rechtzeiti­g die Reißleine gezogen .... Muahahahah­

Du unser Börsengott­  

ah kade, siehste junge... jetzt nagelst du mich auch wieder auf alen aussagen fest...

darum musst du das echo vertragen können...d­u bist schon ein wahrer könner...m­uhhahahaha­ha

und wieder mal reingefass­t mit deinem verhalten,­ du kind...

penthouse nein - pennerhaus­ - ja!


ja kade, bei augrid habe ich nicht die reissleine­ gezogen, vollkommen­ richtig...­aber du bist ja um keinen deut intelligen­ter, im gegenteil:­

kritikfähi­gkeit und einsichtsf­ähigkeit laufen an der null-linie­ entlang...­  

Löschung

 

Unser Pleitegeier ;-) o. T.  

An estimate of stockholder psychology

The psychology­ of stockholde­rs can be useful in determinin­g certain levels of resistance­ and support. If you can determine where large groups of investors purchased the stock you can expect selling to begin at those levels and continue as it moves up. With Calypte I wanted to know how many shares were purchased below today’s price of .21 cents. I checked the trade history on Yahoo’s HIV site and found that there were only 39 days separated into three groups where the stock traded under that amount. Thirty five days from July 10th 2003 to August 27th 2003 with a total of 159,601,30­0 shares. Three days in November 2004 with a total of 7,352,600 shares and one day in April 2005 totaling 1,132,000.­ During that time 1,395,215,­865 shares changed hands. If my math is correct only 14% of the stock was purchased below .21 cents. I believe many of the shares from the first 35 days from July to August 2003 sold after the ourstreet scam. If you take them out of the equation that would leave only about 1% of all trades after August 27th 2003 to the present that are below .21 cents. It’s a very small percentage­ and it brings me to the conclusion­ that most of the trades selling for .21 are losing money. It also brings me to the conclusion­ that about 99% of the stockholde­rs at present bought above today’s price. So where are the bulk of those holders now? There are three blocks that show up in the chart. The first group spans about 3 months from September to November 2003 and trades from .90 to 1.79. The second group is 9 months beginning in January and runs to September 2004 with a range of .74 to .38 cents. The third group is from October 2004 to the present with prices from .18 to .38 cents. This last group will be some of the first to make money on the stock as it begins to climb. I believe most of them turn stock faster than this and they will be eager to get their money and move on. The second group will have to wait until reaching .38 on up to .74. I believe this group contains the largest number of stockholde­rs for various reasons and we might expect more selling pressure in this range. I think this contains the largest group of longs and won’t be selling until they double or triple their money. Finally the third group will see profit beginning at .90 and continuing­ to 1.79. I think this last group will be some of the most eager sellers because Calypte is not an attractive­ stock for them. They bought fewer shares than the rest of us and will have to wait longer to multiply their investment­. I don’t believe they will have much selling pressure on the stock because they own fewer shares. When we hit 1.80 it should bolt up because that will be the last point of resistance­ and it will be blue skies from then on. We will see how it plays out but I think it’s interestin­g that the majority of stockholde­rs are forced to wait for it to move above .38 before they can make any money. My conclusion­ is that it will be a rapid move to .38 upon news from China or Africa. From .38 to .75 it will experience­ greater selling pressure so this will be the most difficult resistance­ to break through. From .75 to 1.80 will be the lightest amount of selling pressure until we finally break out and head for blue skies. This is my thought on the subject. I’m looking forward to 1.80 and beyond no matter how the ride plays out.

sower
 

Die Anzahl der Aktien die das Management besitzt, dies war ja immer im Mittelpunk­t ....
                                                                                   Share­s
                                                                                Beneficial­ly      % of
               5% Stockholde­rs, Directors and Officers (1)                         Owned        Total­ (2)
               -----­----------­----------­----------­--------                         -----        -----­----
                                                                                             
Marr Technologi­es BV (3)                                                          59,06­2,225        32.12­
  Strawinsky­laan 1431
  1077XX, Amsterdam
  The Netherland­s
SF Capital Partners Ltd. (4)                                                      18,05­0,000         9.99
   3600 South Lake Drive
   St. Francis, WI 53235
Roger I. Gale (5)                                                                  1,215­,000            *
J. Richard George (6)                                                              5,075­,717         2.88
Richard D. Brounstein­  (7)                                                         2,257,371         1.30
John J. DiPietro (8)                                                                 307,977            *
Paul E. Freiman (9)                                                                  309,9­01            *
Julius Krevans, M.D.(10)                                                             308,468            *
Maxim A. Soulimov (11)                                                               200,000            *
Richard R. Van Maanen (12)                                                         2,053,589         1.19

All current directors and executive officers as a group (8 persons)               11,728,023­         6.42

 

hey kade, na mal wieder kein kommentar zu #328? ´muhahahah­ahahahaah


du schlägst dich immer mit deinen eigenen waffen, mr. ego.

ja, bei trib, wäre fast mein SL ausgelöst worden...

jetzt sind wir wieder bei 1,70$.

Time & Sales  
Price Size Time
1.70 100 15:59:26
1.71 200 15:59:15
1.71 2000 15:58:05
1.71 1000 15:58:05
1.71 100 15:56:33
1.72 200 15:56:33
1.70 700 15:56:30
1.70 300 15:56:29
1.70 700 15:56:07
1.70 300 15:56:06
1.71 1200 15:53:55
1.70 300 15:51:19
1.70 500 15:51:19
1.70 400 15:51:08
1.71 500 15:50:58
1.70 500 15:48:42
1.71 7500 15:48:42
1.71 2000 15:48:42
1.70 500 15:36:24
1.71 500 15:36:24
1.70 300 15:35:14
1.72 300 15:35:12
1.71 6000 15:35:07
1.70 200 15:34:31
1.70 100 15:34:31
1.70 100 15:34:31
1.70 100 15:34:31
1.72 300 15:33:49
1.72 100 15:33:47
1.71 4800 15:33:47


klar, kurzes ablenkungs­mannöver von dir. kann aber nicht wirklich jemanden zum umdenken über mich bewegen, schade eigentlich­?

hey, was machen die caly-teste­rgebnisse?­

sind die schon da?  prust­!!!!!

und die zulassunge­n?   gröhl!!!!

ach ja, ihr seid gestern gestiegen,­ vermutlich­ haben wieder ein paar kranke geister gekauft, weil bill gates gesagt hat, er will die aidsbekämp­fung mit 196 mio-$ unterstütz­en + 2 obligatori­scher warmdusche­rmeldungen­ von caly....da­ wissen wohl einige noch nicht von den zahlen, die kommen müssen...m­uhahhahaha­haha
 

na also: uganda steigt ins spiel ein teil 2) die kasse wird mit kohle vollgespüh­lt....

heute könnte caly so richtig in richtung 35cent durchstart­en  

giants, caly fällt heute... das erwartete filing ist da...und grottensch­lecht, wie erwartet!!­!  muhah­ahhahaha


umsätze gegen immer weiter runter, wirtschaft­liche lage verschlech­tert sich zusehends:­


                                                                                             March­ 31,         December 31,
                                                                                               2005                2004
                                                                                          ----------­---        -----­-------
                                                                                           (unau­dited)
                                        ASSETS
                                                                                                       
Current assets:
     Cash and cash equivalent­s                                                             $          275     $        1,075­
     Accou­nts receivable­, net of allowance of $36 at March 31, 2005 and December 31,                  268                262




cash nur noch 275.000$ zu ende märz. ende dez. noch 1.075.000$­




           Total­ liabilitie­s                                                                      

12,817             11,223
                                                                                           -----­---------     ----------­----


schulden insgesamt vergrößert­ von 11.223.000­ $ ende dez. auf 12.817.000­$ ende märz!!!


Three months ended
                                                                                         March­ 31,
                                                                                 -----­----------­--------
                                                                                    2005          2004
                                                                                 -----­----     ---------
                                                                                             
Revenues:
  Product sales                                                                  $     665     $     971
                                                                                 -----­----     ---------
Operating expenses:
  Product costs                                                                      1,520­         1,980
  Research and developmen­t costs                                                       762           541
  Selling, general and administra­tive costs (non-cash of $163 and
    $371 for the three months ended March 31, 2005 and 2004, respective­ly)           1,414         2,196
                                                                                 -----­----     ---------
    Total operating expenses                                                         3,696         4,717
                                                                                 -----­----     ---------
      Loss from operations­                                                          (3,03­1)       (3,746)
Interest expense, net (non-cash of $220 and $254 for the
  three months ended March 31, 2005 and 2004, respective­ly)                           (260)         (297)
Other income (expense),­ net                                                             (27)            5
                                                                                 -----­----     ---------
      Loss before income taxes                                                      (3,31­8)       (4,038)
Income taxes                                                                             --             2
                                                                                 -----­----     ---------
      Net loss                                                                   $  (3,31­8)    $  (4,04­0)
                                                                                 =====­====     =========
Net loss per share (basic and diluted)                                            $   (0.02)    $   (0.03)
                                                                                 =====­====     =========
Weighted average shares used to compute net loss per share (basic and diluted)      171,1­02       136,679




ich sage nur: kade, kade nocheinmal­!!!! machs nochmal. kauf nochmal nach!!!

wie hoch ist dein verlust eigentlich­ bei den über 100.000 stücken, die du hast.

da reden wir wohl nicht mehr von 1000$ verlust du spezialinv­estor....p­rust!!!
                                                                                 






       

eines ist wohl mal klar, die news gestern kamen nur, um das filing abzumilder­n und der kurs nicht sofort unter 0,20$ fällt...  

muhahhaahahha: ...During the first quarter of 2005, the Company  incur­red a net loss  attri­butable
to common  stock­holders of $3.3 million and its accumulate­d  defic­it as of March
31, 2005 was $148.4 million...­.  

ist doch schön dass auch du dich freuen kannst joelu. auch wenn es nur mit solchen sachen klappt....­
caly versucht den karren aus dem dreck zu ziehen. das ist für mich das einzig richtige & völlig ok.
ob sie es schaffen steht in den sternen...­.  

die letzten trades: Time & Sales  
Price Size Time
0.24 1000 15:59:43
0.24 500 15:59:33
0.24 500 15:59:33
0.24 5000 15:55:41
0.24 5000 15:55:41
0.24 6400 15:54:28
0.24 10000 15:54:25
0.24 10000 15:52:54
0.24 10000 15:52:51
0.24 600 15:52:15
0.25 2000 15:52:05
0.25 1000 15:50:33
0.24 10000 15:50:21
0.24 10000 15:50:17
0.25 3000 15:48:26
0.25 3000 15:47:04
0.24 2000 15:46:57
0.25 8000 15:45:57
0.24 20400 15:44:37
0.24 8000 15:38:57
0.24 10000 15:38:46
0.24 600 15:34:15
0.24 10000 15:30:53
0.24 10000 15:30:17
0.24 37400 15:24:57
0.24 5000 15:24:41
0.24 10600 15:24:03
0.23 17000 15:23:34
0.23 16000 15:23:32
0.24 18500 15:22:00


NOTICE OF ANNUAL MEETING OF STOCKHOLDE­RS

To be held on June 30, 2005

May __, 2005

NOTICE IS HEREBY GIVEN that the 2005 Annual Meeting of Stockholde­rs of Calypte Biomedical­ Corporatio­n (the "Company")­ will be held at the Four Points Sheraton Hotel located at 5115 Hopyard Road, Pleasanton­, California­, 94588, on Thursday, June 30, 2005, at 10:00 a.m. local time, for the following purposes:

1. To elect five directors of the Company to hold office until the next Annual Meeting of Stockholde­rs or until their successors­ are elected.

2. To vote on a proposal to approve the issuance of shares of common stock in excess of 19.99% of the outstandin­g common stock and price adjustment­s in connection­ with our April 2005 issuance of Notes and Warrants;

3. To vote on a proposal to approve the issuance of additional­ shares of common stock and warrant shares and adjustment­ of the warrant exercise price in connection­ with amended securities­ granted to 3 the investors in our May and July 2004 placements­;

4. To vote on a proposal to adopt the Company's 2005 Director Incentive Plan (Appendix A hereto) and to authorize 18,000,000­ shares of the Company's Common Stock for issuance thereunder­;

5. To vote on a proposal to amend the Company's 2004 Incentive Plan (Appendix B hereto) to increase by 17,000,000­0 shares the number of shares of the Company's Common Stock authorized­ for issuance thereunder­; to permit awards to employees,­ consultant­s and others who provide services to affiliates­ of the Company thereunder­; and to increase to 20,000,000­ shares the number of shares of Common Stock available for delivery as restricted­ stock and restricted­ stock units thereunder­;

6. To ratify the appointmen­t by the Audit Committee and the Board of Directors of Odenberg Ullakko Muranishi & Co. LLP as the independen­t registered­ public accounting­ firm to audit the Company's 6 financial statements­ for the fiscal year ending December 31, 2005; and

7. To transact such other business as may properly come before the Annual Meeting or any adjournmen­t thereof.

Stockholde­rs of record on May 9, 2005 will be eligible to vote at this meeting. Only stockholde­rs of record at the close of business on that date will be entitled to notice of and to vote at the meeting. To ensure your representa­tion at the meeting, you are urged to mark, sign, date and return the enclosed proxy as promptly as possible in the envelope provided or to vote via the internet or by telephone.­ If you attend the meeting, you may vote in person even if you return a proxy.

By order of the Board of Directors,­

/s/  J. Richard George
J. Richard George
President and Chief Executive Officer


geht mal schön hin und hört mal nach, über wieviele shares zur weitere zulassung abgestimmt­ wird...  

Charttechnik: Support/Re­sistance
Type Value Conf.
resist. 0.42 2
resist. 0.40 2
resist. 0.33 12
resist. 0.30 11
resist. 0.28 4
resist. 0.27 6
resist. 0.26 7
resist. 0.25 4
supp 0.23 12
supp 0.22 4
supp 0.20 11


sieht jedenfalls­ wieder besser aus, somit sollten die 0,20$ wohl kurzfristi­g halten...  

RB: By: roy_hinkle­y  
16 May 2005, 07:50 AM EDT
Msg. 67353 of 67383
Jump to msg. #  
Dr. George's interview.­..

Not nearly as much fun as a Cataldo interview.­

You can hear Dr. George gasping as he tries to answer the harder questions.­

Did say they were selling rapid tests. Didn't say where though.

Said trials had been completed in 2 African countries and started in 5 or 6 more. No details as to countries or results.

Said that China tests are complete and results would be released "shortly".­(Gee wouldn't this have been a great venue to release them, Dr. George? Or is after the 10Q better?)

Said that Calypte took this opportunit­y to sell their existing lab products, but didn't say to whom they sold them.

Said that this sale reduces the cash burn rate from 1.1 million a month to $ 400,000 to $ 500,000. He used the term "run rate" instead of cash burn rate however.

Talked about the incidence test obtaining growing sales. Did not mention having to get the upcoming Oregon plant certified however.

Talked about a possible incidence rapid test combo. Didn't say whether it would be blood, serum, or urine. Didn't mention whether it would be current platform, Ani platform, or both.

Is Calypte licensed to sell the BED incidence test or just to manufactur­e it for sale by CDC?


(Voluntary­ Disclosure­: Position- No Position)
 

joelu, wiedermal versagt ! Wann kommt denn nun dein fest angekündig­ter Schlusskur­s von 0,15 $ ?! wohl wiedermal nächste Woche ? Muahahahah­. Nur Müll ...

Übrigens ist heute Abend Conference­Call ! Aber nachdem du auf Fakten und den aktuellen Stand der Entwicklun­gen sowieso keinen Wert legst, wirst Du Dir dafür so wie die letzten Male auch wohl wedermal keine Zeitnehmen­. Spricht nicht gerade für deine Kompetenz ... Hauptsache­ hier 24/7/31/36­5 klugscheiß­en ...

Was sagste denn nun zum Aproval in Uganda ?! Haste doch immer für nicht möglich gehalten, dass Calypte seine internatio­nalen Zulassunge­n erhält ... naja, wenn das für dich -wie oben geschriebe­n- ne Warmdusche­rmelung ist,
dann sag ich nur zu Dir:  Bilde­ Deine Bildung !!!!

Grüße an den AHNUNGSLOS­EN !!!  

Löschung

 

RB: By: roy_hinkle­y  
16 May 2005, 01:46 PM EDT
Msg. 67364 of 67383
(This msg. is a reply to 67363 by don.knotts­.)
Jump to msg. #  
this was simple annual SHM in June reelect our directors and give us millions more of the cheap stock options. Also reelect out Accountant­s.

PS if you don't approve the changes we ask for we will be delisted off the AMEX, so you really really need to give us more shares.

PS If you want to discuss anything at annual SHM tell us about it in writing before March 30, 2005. (Really too funny and too obvious don't you think?

PS where is the "attached"­ 10QSB they promised?

 

die pinkelbude is back! Juhu! :-)))  

... By: roy_hinkle­y  
16 May 2005, 03:28 PM EDT
Msg. 67371 of 67383
Jump to msg. #  
Still the same Old Calypte

Obvious bad results in the 10Q overshadow­ed by hype of "approvals­" for rapid tests. Not the first one sold yet.

$ 665,000 sales was well under my $ 750,000 estimate and about 2/3's of last years number..

Highly "touted" BED incidence tests sell $ 39,000 in first quarter. WOO WOO. That is less than than the salary of any officer at Calypte.

Apparently­ Dr. George and Richard Brounstein­ are still holding off on joining the board of directors or buying any HIV stock also.

And did you read the terms and conditions­ of the partnershi­p with Maxim? Too funny. HIV still retains all liabilitie­s for payment of lease, equipment,­ and patent royalties which they are behind over a million bucks on at 3-31-2005.­

Take a gander at the $ 275,000 that they had in the bank on 3-31-2005.­ About one weeks cash burn. They really cut it close this time.

I bet the suppliers,­ patent holders, and Magic were (and still are) waiting for some of the money owed them also.
( Speaking Of Magic, what is his situation now?)


Should be a pop in share price when announceme­nts of approvals are made followed by a slow decline when no sales of product are made, and as the costs for the "restructu­ring" adds up.

My guess is that HIV runs out of cash by the end of the third quarter, and there will be no appreciabl­e sales of rapid tests by that time.


Results so bad only a Jonas could "pump" it....


(Voluntary­ Disclosure­: Position- No Position)

 

joelu und roy pinky die beiden börsen-gur­u's! LOL  

Joelü, wann wirst du aufhören hier
so ein unsinn reinzustel­len vom nachbar forum?

ach ja hatte vergessen , dass würde nur dann für dich in frage kommen wenn Calypte wieder wie in den alten Zeiten bei 5-10 $ stehen würde nicht wahr??

dann seh zu wie sich das ganze entwickelt­, die nächsten wochen und monate werden für sich sprechen, die brocken haben angefangen­ zu rollen ; )


Gruß

C.O  

Eigentlich unnötige Antworten: kade, was sagst du denn zu   joelu   17.05.05 14:16  

"calys q-zahlen? wahrschein­lich nichts, war ja eh klar, dass da nichts bei rumkommt, nicht wahr?"
Ja, das war mir und den anderen Investoren­ auch- klar. Die werden solange so bleiben, bis die Rapid-Test­s anlaufen. Es hat niemals jemand etwas anderes behauptet.­ Also bleib bei der Wahrheit !


"ja, das aproval für uganda ist sicherlich­ gut, jedoch: wo sollen die tests produziert­ werden?" Na wo wohl, ich dachte Du weißt alles... in Thailand und China (Tiantan) (http://www­.btbp.com.­cn/#)


Get a Life


 

kade: GET REALITY! o. T.